These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24867097)

  • 1. High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma.
    Hu GS; Li YQ; Yang YM; Shi W; Liao AJ; Yao YH; Zeng B; Yuan J
    Tumour Biol; 2014 Sep; 35(9):8625-32. PubMed ID: 24867097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GOLP3 is a predictor of survival in patients with hepatocellular carcinoma.
    JianXin J; Cha Y; ZhiPeng L; Jie X; Hao Z; Meiyuan C; ChengYi S
    Clin Invest Med; 2014 Aug; 37(4):E233-42. PubMed ID: 25090263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High GOLPH3 expression is associated with poor prognosis and invasion of hepatocellular carcinoma.
    Li Q; Ma Y; Xu W
    Mol Med Rep; 2015 Jun; 11(6):4315-20. PubMed ID: 25634514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.
    Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway.
    Liu H; Wang X; Feng B; Tang L; Li W; Zheng X; Liu Y; Peng Y; Zheng G; He Q
    BMC Cancer; 2018 Jun; 18(1):661. PubMed ID: 29914442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
    Hu X; He B; Zhou L; Xie H; Zheng S
    Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.
    Wang CH; Li M; Liu LL; Zhou RY; Fu J; Zhang CZ; Yun JP
    Oncotarget; 2015 Dec; 6(39):42118-29. PubMed ID: 26517349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
    Liang H; Ai-Jun J; Ji-Zong Z; Jian-Bo H; Liang Z; Yong-Xiang Y; Chen Y
    Anticancer Drugs; 2019 Feb; 30(2):186-194. PubMed ID: 30418194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
    Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
    BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
    Chen XQ; He JR; Wang HY
    Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic morphogen nodal is associated with progression and poor prognosis of hepatocellular carcinoma.
    Chen J; Liu WB; Jia WD; Xu GL; Ma JL; Ren Y; Chen H; Sun SN; Huang M; Li JS
    PLoS One; 2014; 9(1):e85840. PubMed ID: 24465741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.
    Zhang G; Liu T; Wang Z
    J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Wang JH; Chen XT; Wen ZS; Zheng M; Deng JM; Wang MZ; Lin HX; Chen K; Li J; Yun JP; Luo RZ; Song LB
    PLoS One; 2012; 7(10):e45622. PubMed ID: 23056210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma.
    Guo X; Yang M; Gu H; Zhao J; Zou L
    Cancer Epidemiol; 2013 Oct; 37(5):732-6. PubMed ID: 23731550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
    Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
    Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.